Sarang Patel
Physician Assistant · Royal Oak, MINPI 1841660412
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $529,680 of the $660,343 with a category attached, or 80.2%. 26 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 41.9% of the total. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,960 payments — averaging $336.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$277K
- AbbVie$119K
- Otsuka America Pharmaceutical, Inc.$93K
- Axsome Therapeutics, Inc.$71K
- Alkermes, Inc.$44K
- Vanda Pharmaceuticals Inc.$18K
- plus $38K from 20 others
What the payments were for
- Consulting fees$46,7207%
- Speaking & faculty fees$529,68080%
- Travel & lodging$50,8768%
- Food & beverage$32,8335%
- Education$2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 504 | $276,840 |
| AbbVie(2 entities) | 298 | $119,255 |
| Otsuka America Pharmaceutical, Inc. | 432 | $93,210 |
| Axsome Therapeutics, Inc. | 151 | $71,386 |
| Alkermes, Inc. | 106 | $43,788 |
| Vanda Pharmaceuticals Inc. | 70 | $18,103 |
| Teva Pharmaceuticals USA, Inc. | 59 | $17,944 |
| E.r. Squibb & Sons, L.L.C. | 42 | $7,510 |
| Idorsia Pharmaceuticals US Inc | 26 | $7,483 |
| Lundbeck LLC | 107 | $1,356 |
| Neurocrine Biosciences, Inc. | 31 | $1,237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $443 |
| Indivior Inc. | 18 | $362 |
| Johnson & Johnson | 11 | $283 |
| Supernus Pharmaceuticals, Inc. | 38 | $279 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $268 |
| Sunovion Pharmaceuticals Inc. | 8 | $148 |
| Corium, LLC | 8 | $123 |
| Ironshore Pharmaceuticals Inc. | 3 | $75 |
| Eisai Inc. | 5 | $70 |
| Jazz Pharmaceuticals Inc. | 3 | $61 |
| OWP Pharmaceuticals, Inc. | 2 | $37 |
| Biogen | 1 | $28 |
| Tempus AI, Inc | 1 | $24 |
| Tris Pharma Inc | 1 | $17 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$270,270
- LYBALVI$166,950
- VRAYLAR$115,141
- REXULTI$78,000
- Auvelity$69,208
- Fanapt$17,172
- ABILIFY MAINTENA$9,991
- AUSTEDO$8,752
- UZEDY$8,193
- QUVIVIQ$6,991
- COBENFY$5,621
- ABILIFY ASIMTUFII$3,879
- INGREZZA$885
- ARISTADA$219
- REJOYN$147
- Austedo XR$138
- ARISTADA INITIO$110
How this compares
$660,343 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 46 | $371,061 |
| VraylarCariprazine Hcl | 103 | $143,475 |
| AuvelityDextromethorphan Hbr/Bupropion | 135 | $124,519 |
| RexultiBrexpiprazole | 59 | $86,238 |
| CaplytaLumateperone Tosylate | 43 | $73,111 |
| QuviviqDaridorexant Hcl | 82 | $39,599 |
| TrintellixVortioxetine Hydrobromide | 43 | $27,333 |
| LybalviOlanzapine/Samidorphan Malate | 15 | $24,084 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $16,298 |
| VyvanseLisdexamfetamine Dimesylate | 19 | $7,691 |
| QelbreeViloxazine Hcl | 14 | $7,536 |
| Vilazodone Hcl | 76 | $6,464 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 18 | $5,135 |
| Clozapine | 45 | $4,153 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 20 | $4,013 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,237 | $371,06146 claims |
| AbbVieVraylar | $119,255 | $143,475103 claims |
| Axsome Therapeutics, Inc.Auvelity | $71,386 | $124,519135 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $93,210 | $86,23859 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $276,840 | $73,11143 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $7,483 | $39,59982 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $443 | $35,02462 claims |
| Alkermes, Inc.Lybalvi | $43,788 | $24,08415 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $279 | $7,53614 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $1,544139 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Royal Oak
- Gabrielle DamoreRoyal Oak$200K
- Laura KingRoyal Oak$63K
- Inge HanschuRoyal Oak$21K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.